Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanjivani ParanteralsBOM:531569 -3.05%73 Interest Coverage is 2.93 as of Mar. 2026, which is 84% below its 10-year median of 17.81. GuruFocus rates BOM:531569 with a GF Score™ of 73/100 and a GF Value™ of ₹226.27 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 687 Drug Manufacturers companies, Sanjivani Paranterals ranks worse than 51.97% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sanjivani Paranterals's
Operating Income
for the
three
months ended in Mar. 2026 was ₹9.2 Mil. Sanjivani Paranterals's Interest Expense for the
three
months ended in Mar. 2026 was ₹-3.1 Mil.
Sanjivani Paranterals's interest coverage for the quarter that ended in Mar. 2026 was 2.93.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sanjivani Paranterals's Interest Coverage or its related term are showing as below:
BOM:531569'
s Interest Coverage Range Over the Past 10 Years
Min: 0.47 Med: 17.81 Max: 321.26
Current: 11.49
BOM:531569's Interest Coverage is ranked worse than 51.97% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.7
vs BOM:531569: 11.49
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sanjivani Paranterals Interest Coverage Related Terms
Sanjivani Paranterals Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sanjivani Paranterals's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanjivani Paranterals Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sanjivani Paranterals's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanjivani Paranterals (BOM:531569) has a Interest Coverage of 2.93 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sanjivani Paranterals and its competitors. This is 84% below median its historical median of 17.81. Over the past decade, Sanjivani Paranterals' Interest Coverage has ranged from 0.47 to 321.26. According to the industry distribution chart, Sanjivani Paranterals ranks #357 out of 687 companies in the Drug Manufacturers industry, placing it in the top 52%.
Is Sanjivani Paranterals' Interest Coverage too high?
Sanjivani Paranterals' current Interest Coverage of 2.93 is 84% below median its 10-year median of 17.81. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 321.26. The Drug Manufacturers industry median Interest Coverage is 12.70. Sanjivani Paranterals' value of 2.93 is 76.9% below this industry median. Based on the distribution chart, Sanjivani Paranterals ranks #357 out of 687 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sanjivani Paranterals has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sanjivani Paranterals' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sanjivani Paranterals ranks #357 out of 687 companies for Interest Coverage. This places Sanjivani Paranterals in the lower half of its industry. The industry median Interest Coverage is 12.70. Sanjivani Paranterals' value of 2.93 is 76.9% below this benchmark. Historically, Sanjivani Paranterals' own Interest Coverage has ranged from 0.47 to 321.26 over the past decade. While the company's 10-year median is 17.81 vs. the industry median of 12.70, Sanjivani Paranterals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.70, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanjivani Paranterals's current Interest Coverage of 2.93 is 76.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sanjivani Paranterals and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanjivani Paranterals's current Interest Coverage is 2.93, which is 84% below median its own 10-year median of 17.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanjivani Paranterals stock overvalued right now?
Based on GuruFocus' analysis, Sanjivani Paranterals (BOM:531569) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹226.27, compared to a current price of ₹160.65 — trading 29% below its estimated fair value. The current Interest Coverage is 2.93, which is 84% below median its 10-year median of 17.81 and 76.9% below the Drug Manufacturers industry median of 12.70. Sanjivani Paranterals' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sanjivani Paranterals (BOM:531569), the current Interest Coverage is 2.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanjivani Paranterals (BOM:531569) Overvalued in 2026?
Based on GuruFocus' analysis, Sanjivani Paranterals stock appears to be undervalued.
The current stock price of ₹160.65 is trading 29% below its estimated GF Value™ of ₹226.27.
GuruFocus considers Sanjivani Paranterals to be Modestly Undervalued.
Key valuation signals for BOM:531569:
Interest Coverage: 2.93 (84% below median its 10-year median of 17.81)
GF Value™: ₹226.27 vs. price of ₹160.65 (29% below fair value)
Industry Position: 76.9% below the Drug Manufacturers median (#357 of 687)
No single metric tells the full story. See the BOM:531569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.
73GF Score
Get the complete analysis for BOM:531569
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531569 has been successfully added to your 
